Pilot Testing of an Online Rehabilitation Intervention for People With Heart Failure (PORIAS-HF).
PORIAS-HF
1 other identifier
interventional
40
1 country
1
Brief Summary
The inability of the heart to pump out blood to the rest of the body organs is called heart failure (HF). HF affects almost 920,000 people in the UK, costing the NHS up to £2.33bn/year. Physical exercise programmes aiming to improve the heart's ability to pump out blood are used to a) reduce the risk of life-threatening events (e.g., heart attack), b) reduce admissions to hospital and c) improve individual's physical independence (e.g., walking unsupported, being able toperform daily essential activities). However, these physical exercise programmes have been cut short under the current COVID-19 pandemic, with support in most UK regions being restricted to online videos and advice. With many people with HF being asked to be "shielded" or "self-isolate" for an unknown duration, it is important to develop a reliable and cost-effective physical exercise service to support this clinical group. The research team has developed a novel physical exercise programme, fully-delivered online. Before assessing if it could improve clinical outcomes (e.g., heart's ability to pump out blood) and how cost-effective it could be, a 10-month pilot study is proposed that will assess if the proposed online physical exercise programme could be performed in people with HF. Thirty participants will be allocated at random into two groups: Group A will receive up to 24 exercise sessions and up-to 3 lifestyle workshops, in addition to usual care over a 2-month period. Group B will receive a self-care exercise programme (≥3 sessions per week) for a two-month period in addition to usual care. Prior to the group random allocation, online assessments will be performed including demographics and clinical history, the ability to perform daily activities, sedentary or physical activity habits and quality of life. The assessments including interviews to assess participant's experiences will be repeated at 2 months
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Jun 2022
Typical duration for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2021
CompletedFirst Posted
Study publicly available on registry
March 15, 2021
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedOctober 15, 2024
October 1, 2024
2.7 years
March 4, 2021
October 10, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Adherence
Number of sessions completed.
2 months
Acceptability of procedures.
Acceptability of procedures will be assessed by examining reasons for drop-out in discontinuing participants and comparing attrition between groups
2 months
Recruitment rates.
Recruitment rates will be measured as rate of invited participants who are eligible and consenting
2 months.
Secondary Outcomes (12)
30-second chair-stand test
Baseline.
30-second chair-stand test
2 months
Step in place test
Baseline
Step in place test
2 months
arm curl test
baseline
- +7 more secondary outcomes
Study Arms (2)
Novel Intervention
EXPERIMENTALNovel Intervention Exercise group.
Control
ACTIVE COMPARATORSelf-managed Exercise group.
Interventions
Group A participants will be invited to attend up to 24 exercise sessions (2 sessions per week and a 3rd optional) and 2 virtual (online; a 3rd will be optional) HF workshops over 8 weeks. All sessions will be delivered via online platforms, with 1 facilitator supporting up to 8 participants simultaneously in each session.
Group B participants will be provided with a self-care exercise programme. The exercise programme will be home-based with a mixture of online video calls and telephone support contacts, alternating once every other week. The video or telephone contacts will be mutually agreed by the patient and the facilitator at a mutually convenient time and will aim to support Group B participants, by offering advice and tracking progress. Patients will be provided with two exercise programmes: I) a chair-based exercise programme (DVD will be provided), and ii) a progressive walking training programme (a manual will be provided). Patients will be advised to exercise ≥3 times per week, starting from their own personal level and gradually building up over 8 weeks in session's duration, frequency of sessions per week, and walking pace.
Eligibility Criteria
You may qualify if:
- Age \> 18 yrs. of either gender
- Confirmed diagnosis (by echocardiography) of HF reduced left ventricular ejection fraction
- Sinus rhythm N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) is \>400 ng/L at the time of referral to the diagnostic clinic if in sinus rhythm.
- Ability to exercise
You may not qualify if:
- Non-ambulant status
- Current pregnancy
- Scheduled major cardiac surgery
- The presence of an ICD or CRT-D device
- Severe pulmonary hypertension defined as systolic PAP of \>60 mmHg
- NYHA function class IV
- Lack of internet connection
- Inability/unwillingness to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sheffield Hallam Universitylead
- King's College Londoncollaborator
- Sheffield Teaching Hospitals NHS Foundation Trustcollaborator
Study Sites (1)
Sheffield Hallam University
Sheffield, Yorkshire, S10 2BP, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markos Klonizakis, D.Phil
Sheffield Hallam University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2021
First Posted
March 15, 2021
Study Start
June 1, 2022
Primary Completion
February 28, 2025
Study Completion
July 30, 2025
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share